FollowTheFilings

Managers Activity Compare Newest

Holders

THERAVANCE BIOPHARMA INC

Q3 2025 13F holders

CUSIP: G8807B106
Type: Equity
Class: COM
Total Reported Value ($000, excl. options)

Manager	Report date	Value ($000)	Shares	Option type

FollowTheFilings · Institutional 13F data room

All managers Activity Compare Newest filings X

Data is sourced from SEC EDGAR as filed. The SEC does not guarantee accuracy or completeness. Holdings exclude shorts and many derivatives; values are as of the report date.